Continuation of therapeutic dose heparin for critically ill patients with COVID-19
Publication date
2023-07
Authors
on behalf of the REMAP-C. A. P. Investigators
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Critical Care and Intensive Care Medicine
Citation
on behalf of the REMAP-C. A. P. Investigators 2023, 'Continuation of therapeutic dose heparin for critically ill patients with COVID-19', Intensive Care Medicine, vol. 49, no. 7, pp. 873-875. https://doi.org/10.1007/s00134-023-07095-8